Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. Our product candidates utilize our proprietary Precisa development platform that are based on specific physical and chemical properties that enable targeted delivery to the exact site of the injury, and provide a controlled and sustained drug release to the affected area.